Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Oskarsson: Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy..... (0.13 sec) 

Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The …


P Oskarsson, JG Ljunggren, PE Lins - Diabetes Care, 1997 - Am Diabetes Assoc
OBJECTIVE: To investigate the efficacy and safety of mexiletine in the treatment
of painful diabetic neuropathy. RESEARCH DESIGN AND METHODS: A total of 216
insulin-treated diabetes patients with painful diabetic neuropathy were ...
Cited by 95 - Related articles - BL Direct - All 7 versions

Mexiletine in the treatment of diabetic neuropathy.


H Stracke, UE Meyer, HE Schumacher, K … - Diabetes Care, 1992 - Am Diabetes Assoc
OBJECTIVE--To prove the efficacy of mexiletine in painful diabetic neuropathy.
RESEARCH DESIGN AND METHODS--Treatment was provided in three dosages. For pain
measurements, a VAS and McGill's verbal rating scale were chosen. ...
Cited by 121 - Related articles - BL Direct - All 6 versions

Mexiletine in the symptomatic treatment of diabetic peripheral neuropathy


JM Wright, JC Oki, L Graves 3rd - The Annals of pharmacotherapy, 1997 - Harvey Whitney Books
OBJECTIVE: To evaluate the efficacy and safety of mexiletine in the symptomatic
treatment of diabetic peripheral neuropathy (DPN). METHODS: In this prospective,
double-blind study, 29 patients were randomized to receive mexiletine 600 ...
Cited by 52 - Related articles - All 4 versions

[CITATION] Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy.


VS Chadda, MS Mathur - The Journal of the Association of Physicians of India, 1978 - ncbi.nlm.nih.gov
1: J Assoc Physicians India. 1978 May;26(5):403-6. Double blind study of the effects
of diphenylhydantoin sodium on diabetic neuropathy. Chadda VS, Mathur MS. ...
Cited by 141 - Related articles

Mexiletine for treatment of chronic painful diabetic neuropathy.


A Dejgard, P Petersen, J Kastrup - Lancet - ncbi.nlm.nih.gov
Sixteen of nineteen patients completed a randomised double-blind crossover trial
to assess the effect of oral mexiletine (10 mg/kg bodyweight daily) on the
symptoms and signs of chronic painful diabetic neuropathy. The median age ...
Cited by 244 - Related articles - All 5 versions

Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol®): …


JA Rull, R Quibrera, H Gonzalez-Millan, OL … - Diabetologia, 1969 - Springer
Symptomatische Behandlung der peripheren diabetisehe~, Neuropathie mit
Garbamazepin (Tegretol) : Doppel-Blind- A ustausch- Untersuchung
Zusammenfassung. An 30 Diabetikern, die unterschied- liche Formen einer ...
Cited by 200 - Related articles - All 2 versions

Phenytoin in the treatment of diabetic symmetrical polyneuropathy.


CD Saudek, S Werns, MM Reidenberg - Clinical pharmacology and therapeutics, 1977 - ncbi.nlm.nih.gov
The efficacy of phenytoin in the treatment of the symptoms of diabetic
symmetrical polyneuropathy has been tested in a double-blind, crossover study.
Symptoms were evaluated daily by linear analogue self-assessment, while ...
Cited by 135 - Related articles

Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic …


G Pérez, J Francisco, R Choza, JM Ríos, A … - Arch. med. res, 1996 - bases.bireme.br
Base de dados : LILACS. Pesquisa : 200357 [Identificador único]. Referências
encontradas : 1 [refinar]. Mostrando: 1 .. 1 no formato [Detalhado]. página 1 de ...
Cited by 71 - Related articles - Cached - BL Direct - All 4 versions

Diabetic peripheral neuropathy: amelioration of pain with transcutaneous electrostimulation.


D Kumar, HJ Marshall - Diabetes Care, 1997 - Am Diabetes Assoc
OBJECTIVE: To evaluate the efficacy of transcutaneous electrotherapy for chronic
painful peripheral neuropathy in patients with type 2 diabetes. RESEARCH DESIGN
AND METHODS: Thirty-one patients with symptoms and signs of peripheral ...
Cited by 96 - Related articles - BL Direct - All 5 versions

The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic …


SH Sindrup, U Bjerre, A Dejgaard, K Brøsen, … - Clinical Pharmacology & Therapeutics, 1992 - nature.com
The effect of the selective serotonin reuptake inhibitor citalopram on diabetic
neuropathy symptoms was examined in a double-blind, placebo-controlled,
crossover study for two 3-week periods. Citalopram was given as a fixed ...
Cited by 173 - Related articles - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google